Nektar Therapeutics (NKTR) Other Accumulated Expenses (2010 - 2026)
Nektar Therapeutics' Other Accumulated Expenses was $9.17 million in Q2 2026, down 40.7% from $15.45 million a year earlier and down 29.6% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Other Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, Other Accumulated Expenses at Nektar Therapeutics came in at $13.98 million, down 3.3% from FY2024.
- Other Accumulated Expenses shows a five-year compound annual growth rate of -7.8% (FY2020 to FY2025).
- In earlier years, Other Accumulated Expenses was $14.45 million in FY2024 (+42.8%), $10.12 million in FY2023 (+44.5%), $7 million in FY2022 (-54.7%) and $15.47 million in FY2021 (-26.3%).
- The Q2 2026 figure marks the lowest quarterly Other Accumulated Expenses since Q1 2024.
- Compared with a year earlier, Other Accumulated Expenses was higher in five of the last eight quarters, with growth averaging 27.0%.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q3 2024 (growth of 157.9%); the worst was Q4 2022 (a decline of 54.7%).
- Per Business Quant data, NKTR's Other Accumulated Expenses in the three quarters before Q2 2026 was $13.02 million (Q1 2026), $13.98 million (Q4 2025) and $12.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Nektar Therapeutics | 1.25 Bn | -515.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.17 Mn |
| Mar 31, 2026 | 13.02 Mn |
| Dec 31, 2025 | 13.98 Mn |
| Sep 30, 2025 | 12.08 Mn |
| Jun 30, 2025 | 15.45 Mn |
| Mar 31, 2025 | 11.82 Mn |
| Dec 31, 2024 | 14.45 Mn |
| Sep 30, 2024 | 17.92 Mn |
| Jun 30, 2024 | 11.06 Mn |
| Mar 31, 2024 | 8.31 Mn |
| Dec 31, 2023 | 10.12 Mn |
| Sep 30, 2023 | 6.95 Mn |
| Dec 31, 2022 | 7.00 Mn |
| Sep 30, 2022 | 15.30 Mn |
| Jun 30, 2022 | 13.04 Mn |
| Mar 31, 2022 | 17.01 Mn |
| Dec 31, 2021 | 15.47 Mn |
| Sep 30, 2021 | 19.97 Mn |
| Jun 30, 2021 | 16.40 Mn |
| Mar 31, 2021 | 14.83 Mn |
API Access
Nektar Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();